Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SAWYER, Michael B")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 30

  • Page / 2
Export

Selection :

  • and

SIZE AND SHAPE MEASUREMENTS OF ASH PARTICLES FROM THE MAY 18, 1980, ERUPTION OF MOUNT ST. HELENS = MESURES DE TAILLE ET DE FORME DES PARTICULES DE CENDRES EMISES PAR L'ERUPTION DU MONT SAINT HELENS DU 18 MAI 1980ZIELINSKI ROBERT A; SAWYER MICHAEL B.1981; OPEN-FILE REP. (U. S. GEOL. SURV. 1978); ISSN 0196-1497; USA; DA. 1981; NO 81-0114; 18; BIBL. 6 REF.; ILL.Serial Issue

Pharmacogenetics of paclitaxel metabolismSPRATLIN, Jennifer; SAWYER, Michael B.Critical reviews in oncology/hematology. 2007, Vol 61, Num 3, pp 222-229, issn 1040-8428, 8 p.Article

Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast CancersSLUPSKY, Carolyn M; STEED, Helen; WELLS, Tiffany H et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5835-5841, issn 1078-0432, 7 p.Article

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicityPRADO, Carla M. M; LIMA, Isac S. F; BARACOS, Vickie E et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 93-101, issn 0344-5704, 9 p.Article

Bolus Oral Glutamine Protects Rats against CPT-11-Induced Diarrhea and Differentially Activates Cytoprotective Mechanisms in Host Intestine but Not TumorHONGYU XUE; SAWYER, Michael B; FIELD, Catherine J et al.The Journal of nutrition. 2008, Vol 138, Num 4, pp 740-746, issn 0022-3166, 7 p.Article

The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapyBIONDO, Patricia D; BRINDLEY, David N; SAWYER, Michael B et al.Journal of nutritional biochemistry. 2008, Vol 19, Num 12, pp 787-796, issn 0955-2863, 10 p.Article

RENAL CONSERVATION OF FOLATES : ROLE OF FOLATE TRANSPORT PROTEINSDAMARAJU, Vijaya L; CASS, Carol E; SAWYER, Michael B et al.Vitamins and hormones. 2008, Vol 79, pp 185-202, issn 0083-6729, 18 p.Article

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine CytotoxicityDAMARAJU, Vijaya L; SCRIVER, Tara; MOWLES, Delores et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 176-186, issn 1078-0432, 11 p.Article

UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenibMEZA-JUNCO, Judith; CHU, Quincy S.-C; CHRISTENSEN, Olaf et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 1-4, issn 0344-5704, 4 p.Article

Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry Determination of Estrogen Conjugates in Human UrineFENG QIN; ZHAO, Yuan-Yuan; SAWYER, Michael B et al.Analytical chemistry (Washington, DC). 2008, Vol 80, Num 9, pp 3404-3411, issn 0003-2700, 8 p.Article

Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidneyDAMARAJU, Vijaya L; ELWI, Adam N; SAWYER, Michael B et al.American journal of physiology. Renal physiology. 2007, Vol 62, Num 1, issn 1931-857X, F200-F211Article

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexMARTIN, Lisa; BIRDSELL, Laura; MACDONALD, Neil et al.Journal of clinical oncology. 2013, Vol 31, Num 12, pp 1539-1547, issn 0732-183X, 9 p.Article

Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?PRADO, Carla M; SAWYER, Michael B; GHOSH, Sunita et al.The American journal of clinical nutrition. 2013, Vol 98, Num 4, pp 1012-1019, issn 0002-9165, 8 p.Article

One-Pot methylation in glycomics application : Esterification of sialic acids and permanent charge constructionXIN LIU; XIANYU LI; CHAN, Kenneth et al.Analytical chemistry (Washington, DC). 2007, Vol 79, Num 10, pp 3894-3900, issn 0003-2700, 7 p.Article

A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphineSAWYER, Michael B; INNOCENTI, Federico; COOK, Edwin JR et al.Clinical pharmacology and therapeutics. 2003, Vol 73, Num 6, pp 566-574, issn 0009-9236, 9 p.Article

Phase I study of an oral formulation of ZD9331 administered daily for 28 daysSAWYER, Michael B; RATAIN, Mark J; BERTUCCI, Donna et al.Journal of clinical oncology. 2003, Vol 21, Num 9, pp 1859-1865, issn 0732-183X, 7 p.Article

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancerKIM, Christina A. K; PRICE-HILLER, Julie; CHU, Quincy S et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 1036-1045, issn 0167-6997, 10 p.Article

Nutrition Modulation of Gastrointestinal Toxicity Related to Cancer Chemotherapy: From Preclinical Findings to Clinical StrategyHONGYU XUE; SAWYER, Michael B; WISCHMEYER, Paul E et al.JPEN. Journal of parenteral and enteral nutrition. 2011, Vol 35, Num 1, pp 74-90, issn 0148-6071, 17 p.Article

Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2DAMARAJU, Swathi; DAMARAJU, Vijaya L; MOWLES, Delores et al.Biochemical pharmacology. 2010, Vol 79, Num 1, pp 21-29, issn 0006-2952, 9 p.Article

Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled StudyANTOUN, Sami; BIRDSELL, Laura; SAWYER, Michael B et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1054-1060, issn 0732-183X, 7 p.Article

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine TreatmentPRADO, Carla M. M; BARACOS, Vickie E; MCCARGAR, Linda J et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2920-2926, issn 1078-0432, 7 p.Article

Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma : Characterization of a novel nucleobase transport activityDAMARAJU, Deepti; DAMARAJU, Vijaya L; BRUN, Miranda et al.Biochemical pharmacology. 2008, Vol 75, Num 10, pp 1901-1911, issn 0006-2952, 11 p.Article

Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type K-RAS Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 TrialSIU, Lillian L; SHAPIRO, Jeremy D; NOTT, Louise M et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2477-2484, issn 0732-183X, 8 p.Article

Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell culturesELWI, Adam N; DAMARAJU, Vijaya L; KUZMA, Michelle L et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 289-301, issn 0344-5704, 13 p.Article

Single and combined supplementation of glutamine and n-3 polyunsaturated fatty acids on host tolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11)/ 5-fluorouracil chemotherapy in rats bearing Ward colon tumourHONGYU XUE; LE ROY, Severine; SAWYER, Michael B et al.British journal of nutrition. 2009, Vol 102, Num 3, pp 434-442, issn 0007-1145, 9 p.Article

  • Page / 2